跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA
Approved
STANDARD
XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA
Instituto Grifols S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 3, 2022
Approval ID
f1cf28a4fede75fa
Company
Instituto Grifols S.A.
Type
Standard
Approval Details
Approval Id
f1cf28a4fede75fa
Drug Cima Aemps Name
XEMBIFY 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA
Register Number
86544
Holder Company Name
Instituto Grifols S.A.
Marketing Company Name
Instituto Grifols S.A.
Holder Company Detail Path
/organization/instituto-grifols-sa
Marketing Company Detail Path
/organization/instituto-grifols-sa
Authorization Date
2022-03-03
Dosage Form
SOLUCIÓN INYECTABLE
Dose
200 mg/ml
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Instituto Grifols S.A.
Company Detail Path
/organization/instituto-grifols-sa
Company Information
Pharmaceutical Company Name
INSTITUTO GRIFOLS SA
Country Name
Spain
City Name
parets del valles,barcelona,country_es
Address
CALLE CAN GUASCH (PG LEVANTE) 2
Active Ingredients
INMUNOGLOBULINA HUMANA NORMAL
18-22 PORCENTAJE
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 3, 2022
Approval ID
f1cf28a4fede75fa
Type
Standard
Back to CIMA-AEMPS Approvals
